Guidant ( GDT: chart) revealed that it reached a new deal to be acquired by Johnson & Johnson ( JNJ: chart) as it offered a higher value of $23.2 billion, an increase compared to J&J''s previous bid, but still below the $25 billion offered by Boston Scientific ( BSX: chart). |